NCT00057174View on ClinicalTrials.gov

Economic Impact of Guidelines for Gastroesophageal Reflux Disease

NACompletedINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2004

Conditions
Gastroesophageal Reflux DiseaseHealth Economics
Interventions
DRUG

Disease management of gastroesophageal reflux disease

Trial Locations (1)

48105

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

US Department of Veterans Affairs

FED

NCT00057174 - Economic Impact of Guidelines for Gastroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter